Millipore Sigma Vibrant Logo

530647 Orai1/CRAC Blocker, Cpd5J-4 - CAS 827001-82-1 - Calbiochem

A non-toxic thiourea derivative that acts as a blocker of Orai1, the pore subunit of Ca2+-release-activated Ca2+ (CRAC) in T cells

Orai1/CRAC Blocker, Cpd5J-4 - CAS 827001-82-1 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Orai1 Inhibitor, CRAC Inhibitor, Ca2+ release-activated Ca2+ (CRAC) channel blocker

Primary Target: Orail1
View This Product on Sigma-Aldrich
530647
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
827001-82-1C₁₆H₁₂N₂O₃S

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
5.30647.0001
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 ｶﾞﾗｽﾋﾞﾝ 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA non-toxic thiourea derivative that acts as a blocker of Orai1, the pore subunit of Ca2+-release-activated Ca2+ (CRAC) in T cells. Exhibits a strong blocking effect on store-operated Ca2+ entry in HeLa-O+S cells and in Th17 cells. Preferentially reduces Th17 differentiation and ameliorates Th17-mediated autoimmune disease. Blocks the infiltration of T cells into the CNS and reduces the number of IL-17 producing cells. Also shown to reduce the expression of retinoic acid receptor-related orphan receptors a (RORa) and RORgt. Reduces the symptoms and delays the onset of experimental autoimmune encephalomyelitis (EAE) in myelin oligodendrocyte glycoproteins 35-55 (MOG35-55) immunized mice (2 mg/kg, i.p.).

      Please note that the molecular weight for this compound is batch-specific due to variable water content.
      Catalogue Number530647
      Brand Family Calbiochem®
      SynonymsOrai1 Inhibitor, CRAC Inhibitor, Ca2+ release-activated Ca2+ (CRAC) channel blocker
      References
      ReferencesKim, K., et al. 2014. J Immunol. 192, 110.
      Product Information
      CAS number827001-82-1
      FormOff-white powder
      Hill FormulaC₁₆H₁₂N₂O₃S
      Chemical formulaC₁₆H₁₂N₂O₃S
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetOrail1
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      5.30647.0001 04055977260991

      Documentation

      Orai1/CRAC Blocker, Cpd5J-4 - CAS 827001-82-1 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      参考資料

      参考資料の概要
      Kim, K., et al. 2014. J Immunol. 192, 110.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-June-2014 JSW
      SynonymsOrai1 Inhibitor, CRAC Inhibitor, Ca2+ release-activated Ca2+ (CRAC) channel blocker
      DescriptionA non-toxic thiourea derivative that acts as a blocker of Orai1, the pore subunit of Ca2+-release-activated Ca2+ (CRAC) in T cells. Exhibits a strong blocking effect on store-operated Ca2+ entry in HeLa-O+S cells and in Th17 cells. Preferentially reduces Th17 differentiation and ameliorates Th17-mediated autoimmune disease. Blocks the infiltration of T cells into the CNS and reduces the number of IL-17 producing cells. Also shown to reduce the expression of retinoic acid receptor-related orphan receptors a (RORa) and RORgt. Reduces the symptoms and delays the onset of experimental autoimmune encephalomyelitis (EAE) in myelin oligodendrocyte glycoproteins 35-55 (MOG35-55) immunized mice (2 mg/kg, i.p.).
      FormOff-white powder
      Intert gas (Yes/No) Packaged under inert gas
      CAS number827001-82-1
      Chemical formulaC₁₆H₁₂N₂O₃S
      Purity≥98% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesKim, K., et al. 2014. J Immunol. 192, 110.